These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12007719)

  • 1. Comparison of anti 60 and 52 kDa SS-A/Ro antibodies in the pathogenesis of cutaneous lupus erythematosus.
    Yoshimasu T; Hiroi A; Ohtani T; Uede K; Furukawa F
    J Dermatol Sci; 2002 May; 29(1):35-41. PubMed ID: 12007719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratinocytes from patients with lupus erythematosus show enhanced cytotoxicity to ultraviolet radiation and to antibody-mediated cytotoxicity.
    Furukawa F; Itoh T; Wakita H; Yagi H; Tokura Y; Norris DA; Takigawa M
    Clin Exp Immunol; 1999 Oct; 118(1):164-70. PubMed ID: 10540174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinuclear antibody-keratinocyte interactions in photosensitive cutaneous lupus erythematosus.
    Furukawa F
    Histol Histopathol; 1999 Apr; 14(2):627-33. PubMed ID: 10212823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic lupus erythematosus in patients with chronic cutaneous (discoid) lupus erythematosus. Clinical and laboratory findings in seventeen patients.
    Callen JP
    J Am Acad Dermatol; 1985 Feb; 12(2 Pt 1):278-88. PubMed ID: 3871800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estradiol enhances binding to cultured human keratinocytes of antibodies specific for SS-A/Ro and SS-B/La. Another possible mechanism for estradiol influence of lupus erythematosus.
    Furukawa F; Lyons MB; Lee LA; Coulter SN; Norris DA
    J Immunol; 1988 Sep; 141(5):1480-8. PubMed ID: 2457617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus.
    David-Bajar KM; Bennion SD; DeSpain JD; Golitz LE; Lee LA
    J Invest Dermatol; 1992 Sep; 99(3):251-7. PubMed ID: 1512459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunofluorescent profile of dermatomyositis: a comparative study with lupus erythematosus.
    Magro CM; Crowson AN
    J Cutan Pathol; 1997 Oct; 24(9):543-52. PubMed ID: 9404851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus.
    Li Q; Wu H; Liao W; Zhao M; Chan V; Li L; Zheng M; Chen G; Zhang J; Lau CS; Lu Q
    J Autoimmun; 2018 Sep; 93():1-15. PubMed ID: 30017673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoimmunology of lupus erythematosus and dermatomyositis: a speculative review.
    Sontheimer RD
    Photochem Photobiol; 1996 May; 63(5):583-94. PubMed ID: 8628749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Ro/SS-A antibodies in lupus erythematosus: what does it mean for the dermatologist?
    Böckle BC; Stanarevic G; Sepp NT
    J Am Acad Dermatol; 2013 Mar; 68(3):385-94. PubMed ID: 23069705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence of anti-basement membrane zone antibodies in the sera of patients with non-bullous lupus erythematosus.
    Ishikawa O; Zaw KK; Miyachi Y; Hashimoto T; Tanaka T
    Br J Dermatol; 1997 Feb; 136(2):222-6. PubMed ID: 9068736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus.
    Furukawa F; Kashihara-Sawami M; Lyons MB; Norris DA
    J Invest Dermatol; 1990 Jan; 94(1):77-85. PubMed ID: 2132545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of RNP, Sm, and SS-A/Ro-specific antisera from patients with lupus erythematosus in inducing antibody-dependent cellular cytotoxicity (ADCC) of targets coated with nonhistone nuclear antigens.
    Norris DA; Ryan SR; Fritz KA; Kubo M; Tan EM; Deng JS; Weston WL
    Clin Immunol Immunopathol; 1984 Jun; 31(3):311-20. PubMed ID: 6609040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-year retrospective clinicohistological study of cutaneous lupus erythematosus in Korea.
    Oh EH; Kim EJ; Ro YS; Ko JY
    J Dermatol; 2018 Apr; 45(4):436-443. PubMed ID: 29423919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-dependent cellular cytotoxicity and skin disease.
    Norris DA; Lee LA
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):165s-175s. PubMed ID: 3874244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between antinuclear and anti-Ro/SS-A antibodies in subacute cutaneous lupus erythematosus.
    Deng JS; Sontheimer RD; Gilliam JN
    J Am Acad Dermatol; 1984 Sep; 11(3):494-9. PubMed ID: 6384294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic sclerosis (scleroderma) associated with discoid lupus erythematosus.
    Sasaki T; Nakajima H
    Dermatology; 1993; 187(3):178-81. PubMed ID: 8219419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility to UVB light in cultured keratinocytes of cutaneous lupus erythematosus.
    Furukawa F; Kanauchi H; Imamura S
    Dermatology; 1994; 189 Suppl 1():18-23. PubMed ID: 8049557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17 in cutaneous lupus erythematosus.
    Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
    Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining risk factors for developing systemic lupus erythematosus in patients with discoid lupus erythematosus.
    Chong BF; Song J; Olsen NJ
    Br J Dermatol; 2012 Jan; 166(1):29-35. PubMed ID: 21910708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.